FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

702409007: Vilanterol trifenatate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2995865011 Vilanterol trifenatate (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2995892017 Vilanterol trifenatate en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vilanterol trifenatate Is a Vilanterol false Inferred relationship Existential restriction modifier
Vilanterol trifenatate Has disposition Beta adrenergic receptor agonist false Inferred relationship Existential restriction modifier
Vilanterol trifenatate Has disposition Beta-2 adrenergic receptor agonist true Inferred relationship Existential restriction modifier
Vilanterol trifenatate Is a Substance with beta-2 adrenergic receptor agonist mechanism of action true Inferred relationship Existential restriction modifier
Vilanterol trifenatate Is modification of Vilanterol true Inferred relationship Existential restriction modifier
Vilanterol trifenatate Is a Chlorinated hydrocarbon true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pharmaram Ltd) Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (Pharmaram Ltd) 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Anoro Ellipta 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Ennogen Healthcare Ltd) Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Ennogen Healthcare Ltd) 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (J M McGill Ltd) 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Generic Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier
Trelegy Ellipta 92micrograms/dose / 55micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd) 30 dose Has specific active ingredient True Vilanterol trifenatate Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start